The store will not work correctly when cookies are disabled.
2-((3-(pyrimidin-2-yl)pyridin-2-ylamino)methyl)phenol
ID: ALA3613793
PubChem CID: 122189306
Max Phase: Preclinical
Molecular Formula: C16H14N4O
Molecular Weight: 278.31
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1ccccc1CNc1ncccc1-c1ncccn1
Standard InChI: InChI=1S/C16H14N4O/c21-14-7-2-1-5-12(14)11-20-16-13(6-3-8-17-16)15-18-9-4-10-19-15/h1-10,21H,11H2,(H,17,20)
Standard InChI Key: MMKQRQTVUOSSBU-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2003 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2004 2.9933 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-6.4995 3.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7985 2.9932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7985 1.4932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4994 0.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4994 -0.7575 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2015 -1.5097 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2039 -3.0097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5041 -3.7576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.8020 -3.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7996 -1.5056 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
3 7 1 0
4 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
15 16 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 278.31 | Molecular Weight (Monoisotopic): 278.1168 | AlogP: 2.86 | #Rotatable Bonds: 4 |
Polar Surface Area: 70.93 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.23 | CX Basic pKa: 5.48 | CX LogP: 2.79 | CX LogD: 2.78 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -0.80 |
References
1. Pollock J, Borkin D, Lund G, Purohit T, Dyguda-Kazimierowicz E, Grembecka J, Cierpicki T.. (2015) Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein-Ligand Complexes., 58 (18): [PMID:26288158] [10.1021/acs.jmedchem.5b00975] |